Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
Saskia M. Rombach(Erasmus MC), Johannes M. F. G. Aerts(Leiden University Medical Center), Natashe Lemos Dekker(Amsterdam UMC Location University of Amsterdam), Carla E. M. Hollak(Centre For Development Studies), J.E.M. Groener(Amsterdam UMC Location University of Amsterdam), Frits A. Wijburg(Emma Kinderziekenhuis), Sara Z. Kuiper(Amsterdam UMC Location University of Amsterdam), M. A. vd Bergh Weerman(Amsterdam UMC Location University of Amsterdam), Machtelt G. Bouwman(Amsterdam UMC Location University of Amsterdam), Gabor E. Linthorst(Geneeskundige en Gezondheidsdienst), A. H. Zwinderman(Amsterdam UMC Location University of Amsterdam), Ben J. H. M. Poorthuis(Amsterdam UMC Location University of Amsterdam)
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
May 17, 2010
Cited by 229
Related Papers
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
|Proceedings of the National Academy of Sciences|2008|725
Proposed guidelines for the diagnosis and management of methylmalonic and propionic acidemia
|Orphanet Journal of Rare Diseases|2014|713
Identification of a Novel Acidic Mammalian Chitinase Distinct from Chitotriosidase
|Journal of Biological Chemistry|2001|511
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
|Molecular Genetics and Metabolism|2012|478
Characterization of Classical and Nonclassical Fabry Disease: A Multicenter Study
|Journal of the American Society of Nephrology|2016|421